Suominen launches three new FIBRELLA® products in its Medical product portfolio

Helsinki, Finland, 2015-11-16 09:00 CET (GLOBE NEWSWIRE) -- Suominen Corporation   Press release   16 November 2015 at 10:00 EET

Suominen launches three new FIBRELLA® products in its Medical product portfolio

Suominen, a leading supplier of nonwovens, today announces the launch of three new products in its Medical business segment at the global Medica exhibition in Düsseldorf, Germany. Medical and Hygiene, which together form the Care Business Area at Suominen, are key focus areas for future growth and product innovation.

FIBRELLA® Zorb and FIBRELLA® Zorb+ are both new nonwoven products designed for use in the Operating Rooms (OR) in hospitals for critical surgical applications. Used as specially tailored additions to standard draping techniques to isolate the patient and OR staff, FIBRELLA® Zorb and FIBRELLA® Zorb+ bring added value benefits to the critical care environment.

FIBRELLA® Zorb is an absorbent light weight top layer with a new texture utilizing Suominen´s unique patterning.

FIBRELLA® Zorb+ is a highly absorbent structure designed for use around the incision site for fenestrations in surgical drapes.

FIBRELLA® Perf, a range of nonwovens for wound care and gentle cleansing has an apertured structure which makes it very soft and skin friendly. FIBRELLA® Perf for Medical applications, initially introduced to the market in South America in March, is now manufactured at all Suominen’s manufacturing sites around the world opening up new geographies for its sale.

Speaking about these new product introductions at Medica, Lynda Kelly, SVP Care business area, said “Our strategic plans to develop and grow in the medical market is clearly reflected in these exciting new FIBRELLA® products which bring high value added benefits to our customers and patients alike. High performance nonwovens offer improved standards of care to the healthcare professionals around the globe.”

“Suominen’s commitment to the medical market with new manufacturing and R&D resources means we will be able to continue to develop new and differentiated products for the specialist medical arena” added Marika Mäkilä, Global Medical Product Manager.

For further information, please contact

Ms Marika Mäkilä, Product Manager, tel. +358 50 384 4014 or

Suominen in brief

Suominen manufactures nonwovens as roll goods for wipes as well as for medical and hygiene products. The end products made of Suominen’s nonwovens – wet wipes, feminine care products and swabs, for instance – bring added value to the daily life of consumers worldwide. Suominen is the global market leader in nonwovens for wipes and employs approximately 600 people in Europe and in the Americas. Suominen’s net sales in 2014 amounted to MEUR 401.8 and operating profit excluding non-recurring items to MEUR 26.9 (continuing operations). The Suominen share (SUY1V) is listed in NASDAQ OMX Helsinki Stock Exchange. Read more at

Latest news

Calendar of Events, European Regulatory News

Change in the publishing date of Suominen’s Interim Report for January-September 2024

Interim report, European Regulatory News

Suominen Corporation’s Interim Report for January 1 – March 31, 2024: Gradual improvement in profitability

Annual Meetings & Shareholder Rights, European Regulatory News

Decisions taken by Suominen’s Annual General Meeting and the Board of Directors